Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2000
11/09/2000WO2000066759A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
11/09/2000WO2000066758A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000WO2000066710A2 Method for the preservation of viruses and mycoplasma
11/09/2000WO2000066155A1 Methods for preventing reactivation of latent virus and controlling virus replication
11/09/2000WO2000032226A3 Xenograft animal model for the induction of papillomas, the production of papillomavirus and the propagation thereof
11/09/2000WO2000031236A3 Vectors for gene mutagenesis and gene discovery by gene trapping
11/09/2000WO2000030668A3 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
11/09/2000CA2371946A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000CA2365277A1 Method for the preservation of viruses and mycoplasma
11/08/2000EP1049788A2 Protein expression in baculovirus vector expression systems
11/08/2000EP1049769A2 Mutant herpes simplex viruses and uses thereof
11/08/2000EP1049678A2 Cyclohexyl and heterocyclyl nucleoside derivatives, method for producing these derivatives, and the use of the derivatives and their oligomers or conjugates in pairing and/or testing systems
11/08/2000CN1272879A Attenuated Japanese encephalitis virus adapted to vero cell and Japanese encephalitis vaccine
11/08/2000CN1272538A Quick high-effective separation and purification method of virus related to rocombinant adenovirus and its application
11/07/2000US6143548 Chromatographic purification of adeno-associated virus (AAV)
11/07/2000US6143547 Cell line derived from Penaeus monodon and a method of growing virus using the same
11/07/2000US6143490 In vitro method for deactivation of viral, bacterial, or protozoan pathogen by adding compound consisting of intercalator nucleic acid binding ligand and an attached mustard group, treating the mixture, and recovering blood
11/07/2000US6143290 Tumor regression by adenovirus expression of wild-type p53
11/07/2000CA2075711C Vaccine and method therefor
11/02/2000WO2000065078A1 A herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
11/02/2000WO2000065075A1 Use of coxsackie viruses for improving cell transfection
11/02/2000WO2000065038A2 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles
11/02/2000WO2000065034A2 Pseudotyped retroviral vector for gene therapy of cancer
11/02/2000WO2000065032A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
11/02/2000WO2000024876A3 Spumavirus isolated from humans
11/02/2000EP1047446A1 Vaccine composition for herpes simplex virus and methods of using
11/02/2000EP1047301A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
11/02/2000EP0683816B1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
11/02/2000DE19549523C2 New proteins from porcine reproductive and respiratory syndrome virus
11/02/2000CA2650236A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
11/02/2000CA2371216A1 Pseudotyped retroviral vector for gene therapy of cancer
11/02/2000CA2370541A1 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles
10/2000
10/31/2000US6140114 Defective viral vaccine particles obtained in vivo or ex vivo
10/31/2000US6140112 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
10/31/2000US6140103 Regulated protein expression in stably transfected mammalian cells
10/31/2000US6140087 Kit for making viral plasmid for treatment of genetic disorders; gene therapy
10/31/2000US6139746 Method employing one or more cross-flow filter elements and one or more types of chromatography resins, in combination, to provide purification with advantageous yield, product purity, and cost- and time-efficiency
10/31/2000CA2132328C Vaccine containing live virus for therapy of viral diseases and malignancies
10/26/2000WO2000062735A2 Treatment of neoplasms with viruses
10/26/2000WO2000035481A3 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/26/2000WO2000034444A3 Method and composition for preserving viruses
10/26/2000WO2000018906A3 Shuffling of codon altered genes
10/25/2000EP1046711A2 Recombinant adeno-associated virus
10/25/2000EP1045921A2 Feline immunodeficiency virus gene therapy vectors
10/25/2000CN1271391A Methods and compositions for therapies using genges encoding secreted proteins such as interferon-beta
10/24/2000US6136586 Methods for the selective modification of viral nucleic acids
10/24/2000US6136585 Attenuation of negative stranded RNA viruses by rearrangement of genes and uses thereof
10/24/2000US6136570 Method for producing RNA viruses from cDNA
10/24/2000US6136322 Genetic engineering
10/24/2000US6136321 Incubation in a polysorbate
10/24/2000US6136318 Genetic engineering
10/24/2000US6136307 Reovirus for the treatment of cellular proliferative disorders
10/19/2000WO2000061804A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000WO2000061790A1 High sensitivity phage display biomolecule detection
10/19/2000WO2000061773A1 Recombinant and mutant adenoviruses derived of bovine adenovirus type 1
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061758A1 Viral variants
10/19/2000WO2000061737A2 Production of attenuated negative stranded rna virus vaccines
10/19/2000WO2000061736A2 Recombinant and mutant marek's disease virus
10/19/2000WO2000061726A1 Composition for the preservation of infectious recombinant adenoviruses
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061613A2 Channel forming toxins as antiviral agents
10/19/2000WO2000061611A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
10/19/2000WO2000061190A2 Treatment of intracellular infection
10/19/2000WO2000036093A3 Intein-mediated cyclization of peptides
10/19/2000CA2760534A1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000CA2372078A1 Treatment of intracellular infection
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2369817A1 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
10/19/2000CA2369200A1 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
10/19/2000CA2368875A1 High sensitivity phage display biomolecule detection
10/19/2000CA2366794A1 Channel forming toxins as antiviral agents
10/19/2000CA2365911A1 Recombinant and mutant adenoviruses derived of bovine adenovirus type 1
10/19/2000CA2365901A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000CA2364562A1 Composition for the preservation of infectious recombinant adenoviruses
10/18/2000EP1044280A1 SELECTIVE KILLING AND DIAGNOSIS OF p53?+ NEOPLASTIC CELLS
10/18/2000EP1044275A1 Mammalian matrix-type metalloprotease
10/18/2000EP1044274A2 Adenoviral vectors with modified capsid proteins
10/18/2000CN1270497A Toxin genes from the bacteria i (xenorhabdus nematophilus) and i (photorhabdus luminescens)
10/17/2000US6133243 Administering to tumor a complex consisting of liposomal viral dna, said viral dna being purified adenoviral dna not in an expression vector and lacking expressed viral oncoprotein that binds to functional p53 tumor suppressor protein
10/17/2000US6133029 Replication defective viral vectors for infecting human cells
10/17/2000US6133028 For gene therapy
10/17/2000US6133024 Recombinant vector which codes for an rna capable of forming a triple helix with target nucleic acid; for transcription of the rna in target cells
10/17/2000US6133015 HHV-8+ lymphoma cell line which is HIV-, CMV-, EBV-, and which produces large amounts of uncontaminated HHV-8 virus
10/17/2000US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
10/17/2000US6132966 Enzymatic nucleic acid which specifically prevents viral replication; for the treatment of transformed hepatocytes and suppression of viral infection humans, animals and primates
10/17/2000US6132732 Parvovirus capsids
10/17/2000US6132731 Murine leukemia virus vectors
10/17/2000CA1341119C Human erythroid-specific transcriptional enhancer
10/12/2000WO2000060127A1 Retrovirus associated with primary sclerosing cholangitis
10/12/2000WO2000060106A1 Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
10/12/2000WO2000060087A2 Cyclin dependent kinase inhibitor genes from plants
10/12/2000WO2000060050A2 Recombinant influenza viruses for vaccines and gene therapy
10/12/2000WO2000034445A3 Live attenuated venezuelan equine encephalitis vaccine
10/12/2000WO2000032227A3 Ordered molecular presentation of antigens, method of preparation and use
10/12/2000CA2367390A1 Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
10/12/2000CA2367385A1 Cell cycle in plants
10/12/2000CA2365526A1 Recombinant influenza viruses for vaccines and gene therapy
10/11/2000EP1043399A2 Hepatitis C Virus cell culture system
10/11/2000EP1042494A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 267